Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection.
Setthapramote C, Sasaki T, Puiprom O, Limkittikul K, Pitaksajjakul P, Pipattanaboon C, Sasayama M, Leuangwutiwong P, Phumratanaprapin W, Chamnachanan S, Kusolsuk T, Jittmittraphap A, Asai A, Arias JF, Hirai I, Kuhara M, Okuno Y, Kurosu T, Ramasoota P, Ikuta K.
Setthapramote C, et al. Among authors: pitaksajjakul p.
Biochem Biophys Res Commun. 2012 Jul 13;423(4):867-72. doi: 10.1016/j.bbrc.2012.06.057. Epub 2012 Jun 17.
Biochem Biophys Res Commun. 2012.
PMID: 22713454